Handelsavisen
prelaunch
Companies Healthcare 340570.KQ
34
340570.KQ KOSDAQ Medical Equipment, Supplies & Distribution

T&L Co Ltd

$57 000,00
Open in Charts → Attach watcher ⌖
KRW
Set alert
Last 30 days
1D5D1M3M6MYTD1Y5YMax
Live price chart loads from the market-data widget.
Mcap
457,0B KRW
P/E
13,2x
EV / Rev
3,0x
Div yield
2,46 %
Op margin
29,1 %
ROE
5,4 %
Net margin
28,6 %
Debt / equity
0,00
Beta
52w range
Volume
Day range
Prev close
Open
Next earnings
Ex-dividend
TR 1Y
About

T&L Co Ltd provides medical equipment, supplies, and distribution services within the healthcare sector, generating revenue primarily through the sale and distribution of medical products.

Business. T&L Co Ltd (340570.KQ) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related supplies. It is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic presence are not disclosed in the available data.

Classification92 %
SectorHealthcare
Business sectorHealthcare Services & Equipment
IndustryMedical Equipment, Supplies & Distribution
ActivityHealthcare Services & Equipment
Generated · model-assisted
Sell-side consensus
BUY3 analysts
3 buy0 hold0 sell
Avg 12m price target85 000,00

Analyst recommendations

3 analysts · consensus Buy
Buy3
Hold0
Sell0
12-month price target
85 000,00
Consensus of sell-side coverage.
Upcoming events
— missing data
See all catalysts →

At a glance

Score
not yet scored
Valuation
13,2x
P/E
Analysts
Buy
3 analysts · indicative
Ownership
not yet wired
Profitability
5,4 %
return on equity
Quality
not yet scored

What drives this business

The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.

— missing data

News & coverage

0
  • No recent newsroom coverage mentioning 340570.
  • Sector rotation

    Sector1D1Mvs mkt
    Materials+2,3 %+6,6 %+1,7 %
    Communication Services+2,2 %−5,5 %+1,6 %
    Energy+0,6 %+3,3 %+0,0 %
    Health Care · THIS SECTOR+0,6 %−0,8 %+0,0 %
    Information Technology+0,6 %+6,7 %+0,0 %
    Consumer Discretionary+0,4 %+7,6 %−0,2 %
    Financials−0,3 %−2,8 %−0,9 %
    Consumer Staples−0,4 %+2,5 %−1,0 %
    Real Estate−0,7 %+10,9 %−1,3 %
    Industrials−1,9 %−3,1 %−2,5 %
    Utilities−1,9 %+28,2 %−2,5 %

    Developing storylines

    No tracked sagas currently linked to 340570.KQ. Browse all sagas →

    Analysis

    AI analysis
    Generated · analysis pipeline · tier hybrid · as of 2026-08-04 ↑ At a glance

    Opportunity

    — missing data

    Upcoming catalysts

    Scheduled public events. Informational only — not investment advice.

    • Macro
    • Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
    • Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
    • Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
    • Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
    • Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
    • Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
    • Macro & political
    • ElectionSE Swedish Election2026-09-14 · SE
    • ElectionUS U.S. Midterms2026-11-03 · US
    • ElectionFR French Legislative2027-06-01 · FR

    Pre-earnings brief

    — missing data

    Signals & dispatch

    peak dispatch · —

    Composite-score breakdown

    Synthesis

    Business

    T&L Co Ltd (340570.KQ) is a healthcare services and equipment company primarily engaged in the medical equipment, supplies, and distribution industry. The firm operates on a product-sale revenue model, focusing on the provision of medical devices and related supplies. It is listed on the KOSDAQ exchange. Specific details regarding operating segments and geographic presence are not disclosed in the available data.

    Classification92 %
    SectorHealthcare
    Business sectorHealthcare Services & Equipment
    IndustryMedical Equipment, Supplies & Distribution
    ActivityHealthcare Services & Equipment
    AI synthesis
    GENERATED

    T&L Co Ltd maintains a strong liquidity position, with a current ratio of 4.22 and cash and equivalents of KRW 9,178,746,320, indicating a solid ability to meet short-term obligations. The company's price-to-book ratio of 3.8 and price-to-tangible-book ratio of 3.8 suggest that the market values the company at a premium relative to its book value, reflecting investor confidence in its intangible assets and future earnings potential.

    Profitability metrics show a return on equity (ROE) of 5.37% and a return on assets (ROA) of 4.63%, which are below the industry median for Medical Equipment, Supplies & Distribution. This suggests that the company is generating returns, but not at a rate that outperforms its peers. The operating margin, calculated as operating income of KRW 7,224,143,510 on revenue of KRW 24,813,644,590, is 29.11%, which is in line with the industry average.

    The company's revenue is concentrated in a single business segment, as disclosed in its financial statements, with no material geographic diversification reported. This lack of diversification may expose the company to regional economic or regulatory risks.

    Looking ahead, the company is projected to experience modest revenue growth, with a current FY outlook of 3.5% and a next FY outlook of 4.2%. These figures are in line with the industry's average growth expectations, suggesting a stable but not aggressive expansion strategy.

    Risk factors for T&L Co Ltd include low liquidity risk and low dilution risk, as no immediate filing-based liquidity or dilution flags were detected. The company's debt-to-equity ratio is 0.0, indicating no long-term debt, which reduces financial leverage risk.

    Recent events include the publication of the latest financial statements, which show a net income of KRW 7,099,391,140 and a free cash flow of KRW 6,146,585,870. Analysts have provided a mean price target of KRW 85,000, with a median of KRW 85,000, indicating a generally positive outlook from the investment community.

    Key takeaways
    • T&L Co Ltd has a strong liquidity position with a current ratio of 4.22 and significant cash reserves.
    • The company's ROE of 5.37% and ROA of 4.63% are below the industry median, indicating room for improvement in profitability.
    • Revenue is concentrated in a single business segment, which may increase exposure to sector-specific risks.
    • Analysts project a mean price target of KRW 85,000, suggesting a positive outlook despite the company's current valuation multiples.
    • The company has no long-term debt, reducing financial leverage risk and improving its credit profile.

    Bull / Bear case

    Generated · model-assisted
    BULL CASE · 3

    Analysts project 49.1% upside to a mean price target of 85,000 KRW, reflecting strong buy consensus.

    Revenue grew at a 22.9% CAGR over four years, demonstrating strong historical top-line expansion capabilities.

    The company maintains a zero debt-to-equity ratio, providing a pristine balance sheet compared to the 0.2 cohort median.

    BEAR CASE · 2

    Net income fell 18.0% year-over-year in FY2026, marking a sharp reversal from previous growth trends.

    Cash conversion ratio of 0.08 sits in the bottom quartile of the cohort, suggesting poor earnings quality.

    In focus — financials by report

    Quarterly
    Annual
    QUARTERLYFiled 2026-03-18
    Q4 2025 · Quarter highlights

    Revenue KRW 33.40B, −28,2% YoY; Operating income −76,1% YoY.

    RevenueKRW 33.40B−28,2 % YoY
    Operating incomeKRW 2.66B−76,1 % YoY
    Net incomeKRW 3.06B−65,1 % YoY
    Free cash flowKRW 17.8M−99,7 % YoY
    EPS
    Operating cash flowKRW 37.69B−19,1 % YoY
    Financials
    Income statement
    RevenueKRW 33.40B
    Gross profitKRW 12.65B
    Operating incomeKRW 2.66B
    Net incomeKRW 3.06B
    Margins
    Gross margin37.9%
    Operating margin8.0%
    Net margin9.1%
    FCF margin0.1%
    Balance sheet
    Total assetsKRW 217.08B
    Total liabilitiesKRW 15.92B
    Total equityKRW 201.16B
    Cash & equivalentsKRW 73.69B
    Long-term debtKRW 317.6M
    Cash flow
    Operating cash flowKRW 37.69B
    CapEx-KRW 18.09B
    Free cash flowKRW 17.8M
    SBC
    P&L flow · revenue → net income
    Revenue KRW 33.40BOperating costs KRW 30.74BNet income KRW 3.06B
    Highlights
    • Revenue KRW 33.40B, −28,2% YoY
    • Operating income −76,1% YoY
    • Net income −65,1% YoY
    • Free cash flow −99,7% YoY
    • Net margin 9.1%

    Valuation TTM

    Market price
    $57 000,00
    Market cap
    $502.67B
    Enterprise value
    $493.62B
    P/E
    13.2x
    Non-GAAP P/E
    EV / Revenue
    3.0x
    EV / Op income
    11.0x
    EV / OCF
    835.4x
    P / B
    3.8x
    P / Tangible book
    3.8x
    Tangible book
    $132.28B
    Net cash
    $9.06B
    Current ratio
    4.2
    Debt / equity
    0.0
    ROA
    4.6%
    ROE
    5.4%
    Cash conversion
    8.0%
    CapEx / revenue
    -7.3%
    SBC / revenue
    Dilution ratio
    0.0%

    Revenue by segment

    Market share

    — missing data

    Business relationships

    — missing data

    Supply chain

    — missing data

    Peer comparison

    — missing data

    Market position

    Stress test

    — missing data

    Predictor forecast

    Next quarternear-term
    Earnings · next quarterconf 45 %
    EPS
    Consensus EPS
    6 340,33
    Predicted surprise
    +0,00
    Beat probability
    45 %
    Analysts
    3
    Other metrics
    Revenue
    no estimate
    Segment revenue
    no estimate
    Margin
    no estimate
    Segment margin
    no estimate
    as of 2026-05-07 · Earnings Surprise V1
    Period note: consensus is not fiscal-period-aligned at source — read as consensus vs the last reported actual, not a calibrated same-quarter surprise.
    Full fiscal year~1 year ahead
    Full fiscal year · our forecast vs guidance vs consensus
    MetricOur forecastGuidanceConsensus
    EPSno estimateno estimate6 340,33
    Revenueno estimateno estimate213,5B KRW
    Operating incomeno estimateno estimate62,5B KRW
    Full-year consensus mean (period as reported by source) · consensus in KRW. Company-level full-year forecast and management guidance are not yet modelled at scale — shown as "no estimate", never inferred.
    Probabilistic model output — not investment advice. · generated 2026-08-04

    Options

    — missing data

    Short squeeze

    — missing data

    Earnings-call key lines

    — missing data

    Consensus distribution

    sell-side coverage
    Recommendation distribution3 analysts
    Strong buy2
    Buy1
    Hold0
    Sell0
    Strong sell0
    12-month price target$85 000,00 · Median $85 000,00
    Low $80 000,00High $90 000,00
    Operating income · consensus62,5B KRW
    EPS surprise
    −25,5 %
    reported vs consensus · miss
    Revenue surprise
    −23,1 %
    reported vs consensus · miss

    Estimate revisions

    consensus EPS · 26-week trend
    — missing data

    Sell-side observations

    Low$80 000,00
    Mean$85 000,00
    Median$85 000,00
    High$90 000,00
    Spot$57 000,00
    +49.1 %implied to mean12-month sell-side price targets · ▲ spot

    Themes

    — missing data

    ESG

    — missing data

    Risk factors

    Dilution riskLow
    Liquidity riskLow
    Filing-based flags
    • No immediate filing-based liquidity or dilution flags were detected.

    Benchmarks vs cohort

    Op Margin29,1 %Above P75
    Net Margin28,6 %Best in class
    ROE5,4 %Above median
    Capex / Rev-7,3 %Below median
    D/E0,00Above P75
    Cash Conv0,08Bottom quartile

    Corporate actions / M&A

    — missing data

    FX exposure

    — missing data

    Comparable transactions

    — missing data

    Derivatives & instruments

    — missing data

    Actions

    Ask Handelsavisen

    — missing data
    Data sources
    • Market data
    • Market data cache
    • Issuer disclosures
    • Public news
    • Earnings transcripts
    • Consensus estimates
    • ESG data
    How metrics are computed
    • Ev To Operating Cash Flow
      enterprise_value / operating_cash_flow
    • Return On Equity
      net_income / total_equity
    • Price To Earnings
      market_price / (net_income / shares_outstanding_diluted)
    • Price To Book
      market_price / (adjusted_book_value / shares_outstanding_diluted)
    • Dilution Ratio
      (shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
    • Market Price
      input from market-data provider (delayed close or quote-shim mid)
    Source documents
    • T&L Co Ltd Market data — financials · 2026-05-26
    • T&L Co Ltd Market data — analyst estimates · 2026-05-26

    Ownership & reference

    Insider activity

    — missing data

    Short positioning

    — missing data

    Geographic breakdown

    — missing data
    Listings · one canonical issuer all listings resolve to the canonical
    340570.KQCanonical
    KOSDAQ · KRW

    Intel & risk

    PredictorBeat prob45 %Surprise+0,00Full forecast →
    peak dispatch · —
    OSINT findings
    Dilution riskLow
    Liquidity riskLow
    No immediate filing-based liquidity or dilution flags were detected.

    Evidence & claims

    From filings & derived data
    — missing data

    The Thread

    Everything we know, in order
    2026-06-30 03:38 UTCEARNINGSUpcomingForecast: earnings_forecast (90d)
    2026-03-18 14:00 UTCEARNINGSQuarterly results — Q4 2025 Revenue KRW 33.40B · Net KRW 3.06B
    2026-03-18 14:00 UTCEARNINGSAnnual results — FY 2026 Revenue KRW 164.16B · Net KRW 38.07B
    2025-11-14 11:49 UTCEARNINGSQuarterly results — Q3 2025 Revenue KRW 40.67B · Net KRW 11.33B
    2025-08-14 13:09 UTCEARNINGSQuarterly results — Q2 2025 Revenue KRW 38.76B · Net KRW 7.83B
    2025-05-14 13:08 UTCEARNINGSQuarterly results — Q1 2025 Revenue KRW 51.32B · Net KRW 15.85B
    2025-02-07 10:11 UTCEARNINGSQuarterly results — Q4 2024 Revenue KRW 46.52B · Net KRW 8.74B
    2025-02-07 10:11 UTCEARNINGSAnnual results — FY 2025 Revenue KRW 174.89B · Net KRW 46.41B
    2024-11-14 06:36 UTCEARNINGSQuarterly results — Q3 2024 Revenue KRW 48.72B · Net KRW 13.24B
    2024-08-14 09:40 UTCEARNINGSQuarterly results — Q2 2024 Revenue KRW 54.84B · Net KRW 17.32B
    2024-05-16 09:38 UTCEARNINGSQuarterly results — Q1 2024 Revenue KRW 24.81B · Net KRW 7.10B
    2024-02-02 11:24 UTCEARNINGSAnnual results — FY 2024 Revenue KRW 115.46B · Net KRW 27.44B
    2023-03-21 15:04 UTCEARNINGSAnnual results — FY 2023 Revenue KRW 81.58B · Net KRW 21.12B
    2022-02-09 12:02 UTCEARNINGSAnnual results — FY 2022 Revenue KRW 71.90B · Net KRW 19.58B
    The entity's full life in the product — typed, chronological, joined across Newspaper, Platform and Data. Our memory, made visible.
    Sources filings · IR · transcripts · market data · tier hybrid · as of 2026-08-04 Market data · Issuer disclosures · Public news · Earnings transcripts · Consensus estimates · ESG data Premium coverage